Department of Orthopedics, Xiangtan Central Hospital, Xiangtan, Hunan, China.
Department of Respiratory Medicine, Xiangtan Central Hospital, Xiangtan, Hunan, China.
J Biochem Mol Toxicol. 2021 Aug;35(8):e22832. doi: 10.1002/jbt.22832. Epub 2021 May 24.
Osteoporosis is a serious health problem, especially in geriatric patients. Worldwide, it affects 8.9 million people every year. Oxidative stress and inflammation expand the osteoporosis reaction. Hesperidin supplement helps to decrease inflammation and oxidative stress. In this study, we estimated the antiosteoporotic effect of hesperidin against the ovariectomized (OVX) rat model of osteoporosis. Hesperidin was orally administered at 5, 10, and 20 mg/kg to OVX rats for 10 weeks. Different biochemical parameters, such as alkaline phosphatase (ALP), osteocalcin (OC), phosphorus (P), calcium (Ca), and antioxidant parameters, were also estimated. The three-point bending test, bone mineral density (BMD), and histomorphometric features of the femoral bone were also scrutinized. Hesperidin significantly decreased body weight and increased uterine weight. Hesperidin significantly reduced the ALP, OC, acid phosphatase, and β-isomerized C-terminal telopeptides levels in OVX rats. Hesperidin considerably increased BMD and dose-dependently reduced the pixel density. Hesperidin considerably increased the maximum load, energy, stiffness, maximum stress, and young modulus. Hesperidin significantly (p < 0.001) reduced the levels of thiobarbituric acid reactive substance and increased the level of superoxide dismutase, glutathione, glutathione peroxidase, catalase in OVX-induced rats. Hesperidin significantly diminishes the cytokine levels, such as tumor necrosis factor-α, interleukin-6 (IL-6), and IL-1β, and inflammatory mediators such as nuclear factor-kappa B. It significantly reduced the level of Ca, P, and increased the level of vitamin D in OVX rats. Hesperidin significantly (p < 0.001) reduced the expression of sirtuin 1. Collectively, we can conclude that hesperidin exhibited better protection against osteoporosis by enhancing the bone density and bone mineral content in addition to biomechanical parameters.
骨质疏松症是一个严重的健康问题,特别是在老年患者中。全球范围内,每年有 890 万人受到影响。氧化应激和炎症会加剧骨质疏松症反应。橙皮苷补充剂有助于减轻炎症和氧化应激。在这项研究中,我们评估了橙皮苷对去卵巢(OVX)骨质疏松症大鼠模型的抗骨质疏松作用。橙皮苷以 5、10 和 20mg/kg 的剂量口服给予 OVX 大鼠,持续 10 周。还评估了碱性磷酸酶(ALP)、骨钙素(OC)、磷(P)、钙(Ca)和抗氧化参数等不同生化参数。还检查了三点弯曲试验、骨密度(BMD)和股骨组织形态计量学特征。橙皮苷显著降低了体重,增加了子宫重量。橙皮苷显著降低了 OVX 大鼠的 ALP、OC、酸性磷酸酶和β-异构化 C 端肽水平。橙皮苷显著增加了 BMD,并呈剂量依赖性降低了像素密度。橙皮苷显著增加了最大负荷、能量、刚度、最大应力和杨氏模量。橙皮苷显著(p<0.001)降低了丙二醛含量,增加了超氧化物歧化酶、谷胱甘肽、谷胱甘肽过氧化物酶和过氧化氢酶的水平。橙皮苷显著降低了肿瘤坏死因子-α、白细胞介素-6(IL-6)和 IL-1β等细胞因子以及核因子-κB 等炎症介质的水平。它显著降低了 OVX 大鼠的 Ca、P 水平,增加了维生素 D 水平。橙皮苷显著(p<0.001)降低了 SIRT1 的表达。综上所述,橙皮苷通过增加骨密度和骨矿物质含量以及生物力学参数,对骨质疏松症表现出更好的保护作用。